These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. del Castillo D; Campistol JM; Guirado L; Capdevilla L; Martínez JG; Pereira P; Bravo J; Pérez R Kidney Int Suppl; 1998 Dec; 68():S135-9. PubMed ID: 9839298 [TBL] [Abstract][Full Text] [Related]
23. Using AN69 ST membrane: a dialysis centre experience. Maheut H; Lacour F Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664 [No Abstract] [Full Text] [Related]
24. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan]. Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258 [TBL] [Abstract][Full Text] [Related]
25. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
26. Anaphylactoid reaction during hemodiafiltration on AN69 membrane in a patient with atypical hemolytic uremic syndrome: A pediatric case report. Karakaya Z; Duyu M; Koksal Atis S Hemodial Int; 2022 Jan; 26(1):E8-E11. PubMed ID: 34219382 [TBL] [Abstract][Full Text] [Related]
27. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis. Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH; Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711 [TBL] [Abstract][Full Text] [Related]
29. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients]. García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513 [TBL] [Abstract][Full Text] [Related]
30. Anaphylactoid reactions during hemodialysis on AN69 membranes: role of ACE inhibitors and back-filtration. Perez-Garcia R; Galan A; Garcia Vinuesa M; Anaya F; Valderrabano F Nephron; 1992; 61(1):123. PubMed ID: 1528334 [No Abstract] [Full Text] [Related]
31. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ; Stapff M; Lin Y Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of angiotensin II type 1 receptor antagonists in dialysis patients using AN69 dialysis membranes. Tepel M; van der Giet M; Zidek W Kidney Blood Press Res; 2001; 24(1):71-4. PubMed ID: 11174010 [TBL] [Abstract][Full Text] [Related]
33. The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis. Opatrný K; Krouzecký A; Wirth J; Vít L; Eiselt J Artif Organs; 1998 Oct; 22(10):816-20. PubMed ID: 9790077 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391 [TBL] [Abstract][Full Text] [Related]
35. A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions. Furuta M; Kuragano T; Kida A; Kitamura R; Nanami M; Otaki Y; Nonoguchi H; Matsumoto A; Nakanishi T ASAIO J; 2011; 57(4):293-9. PubMed ID: 21499075 [TBL] [Abstract][Full Text] [Related]
36. AN69: Evolution of the world's first high permeability membrane. Thomas M; Moriyama K; Ledebo I Contrib Nephrol; 2011; 173():119-129. PubMed ID: 21865784 [TBL] [Abstract][Full Text] [Related]
37. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037 [TBL] [Abstract][Full Text] [Related]
38. Oxalate depuration during biofiltration with AN69 and in conventional hemodialysis in chronic renal failure (CRF) patients. Chimienti S; Mele G; Perrone F; Muscogiuri P; Cristofano C Int J Artif Organs; 1986 Dec; 9 Suppl 3():73-4. PubMed ID: 3557678 [TBL] [Abstract][Full Text] [Related]
39. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. Asmar R; Lacourcière Y J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group. Toto R; Shultz P; Raij L; Mitchell H; Shaw W; Ramjit D; Toh J; Shahinfar S Hypertension; 1998 Feb; 31(2):684-91. PubMed ID: 9461241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]